NAMS vs NVAX Stock Comparison

Compare NAMS vs NVAX on performance, valuation, growth, fundamentals, momentum and risk; the current AIQ evidence does not show a clear headline leader.

Market data as of Nov 15, 2026 market close
NAMS
Healthcare
vs
NVAX
Healthcare
NAMS
NewAmsterdam Pharma Company N.V.
Price
$20.14
Day move
+0.85%
AIQ Score
41/100
Best edge
Risk Resilience
Sector
Healthcare
NVAX
Novavax, Inc.
Price
$8.53
Day move
-2.68%
AIQ Score
-/100
Best edge
Momentum
Sector
Healthcare

What is the main difference between NAMS and NVAX?

NAMS and NVAX are close on the current AIQ evidence, so the better fit depends more on objective, risk tolerance and valuation preference than on a single headline score.

AlgovestIQ AIQ Comparison

NewAmsterdam Pharma Company N.V. vs Novavax, Inc.

Data as of Nov 15, 2026· market close· Healthcare· Coverage 60/66 fields· High confidence
AIQ VerdictFragile

NAMS and NVAX are effectively level

NAMS and NVAX are effectively level on the AIQ Score; the factor table below shows where each one holds its advantage.

Evidence agreement: 0 of 4
NAMS

NewAmsterdam Pharma Company N.V.

AIQ Score
41/100
AIQ Edge Score
2/10
NVAX

Novavax, Inc.

AIQ Score
—/100
AIQ Edge Score
—

The Algovestiq AIQ Score does not currently separate NAMS and NVAX as of Nov 15, 2026. Both names are scored on the same 0–100 scale across Quality, Value, Momentum and Risk Resilience, and the factor table below shows where each one holds its advantage.

Compare NewAmsterdam Pharma Company N.V. and Novavax, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Price return from daily closes; distributions are not included.

NAMS
+94.6%
NVAX
-49.9%

Price return comparison

Growth of $10,000, price only

NAMS $19,459 · NVAX $5,006

Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.

Compare NAMS and NVAX against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

NAMS advantage
0
NVAX advantage
  • Momentum22 vs 77
    NVAX +55
  • Risk Resilience48 vs 38
    NAMS +10
  • Quality58 vs 62
    NVAX +4

Neither name separates cleanly on the covered dimensions.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

NAMS0 AIQ

Largest factor move: Value +2, not enough on its own to move the overall score.

No signal started or stopped since the prior session; its 6 active signals are unchanged.

NVAX

Largest factor move: Momentum +3

No signal started or stopped since the prior session; its 6 active signals are unchanged.

Deeper signal detail for each name lives on its own signals page — NAMS and NVAX both carry a full feed there.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

Even

Neither separates on the overall score.

Growth

NAMS

NAMS on combined revenue and EPS growth.

Value

Even

The two are level on Value.

Momentum

NVAX

NVAX on the Momentum factor, by 55 points.

Lower downside

NAMS

NAMS on Risk Resilience, by 10 points.

Analyst upside

NAMS

NAMS on implied upside to the consensus price target.

AIQ vs Wall Street

Where the systematic read and the analyst consensus line up — and where they do not.

MeasureNAMSNVAXNote
Implied upside to target+202.9%-6.2%NAMS has more room
Target dispersion0%0%Lower is tighter analyst agreement
ConsensusBuyHoldContext, not a primary driver
Analysts covering169Higher coverage generally improves confidence

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

How each independent group of evidence reads the pair.

Evidence groupFavorsReading
AIQ ScoreNot coveredNot covered
FundamentalsNAMSon balancerevenue growth 4.2% vs 20.5%; EPS growth 73.1% vs 40.6%; TTM ROE -2.8% vs 14.5%; gross margin 97.8% vs 77.3%; operating margin -9% vs -19.6% — NAMS takes 3 of 5 decided legs, not all of them
ValuationNot coveredNot covered
TechnicalsNVAXPrice vs 50-day -6.4% vs -19.1%; vs 200-day -30.9% vs -8.7%
Risk ResilienceNAMSRisk Resilience 48 vs 38
Analyst expectationsNAMSTarget upside 202.9% vs -6.2%

AIQ Decision Stability

Fragile

The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.

  • Only 0 of 4 covered evidence groups agree. (argues the conclusion is provisional)

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

NAMSConflicted

1 bullish / 3 bearish / 2 neutral, conflicted

Only NAMS

  • Death Cross Active — bearish, trend, long horizon (35.44%)
  • ADX Trend Weakening — neutral, trend, medium horizon
  • Downtrend Structure Active — bearish, trend, long horizon
  • MACD Histogram Expanding Bullish — bullish, momentum, short horizon
NVAXConflicted

2 bullish / 2 bearish / 2 neutral, conflicted

Only NVAX

  • Golden Cross Active — bullish, trend, long horizon (12.89%)
  • ADX Trend Strengthening — neutral, trend, medium horizon
  • BB Lower Band Breach — bullish, volatility, short horizon
  • MACD Histogram Expanding Bearish — bearish, momentum, short horizon

Both carry 2 more signals that do not separate them: ATR Expansion - Breakout Mode, Beta Spike Warning.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

NAMSNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +0.85%, AIQ 0 points).

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

NAMS leads on balance
MetricNAMSNVAX
Revenue growth (YoY)4.2%20.5%
EPS growth (YoY)73.1%40.6%
Gross margin97.8%77.3%
Operating margin-9%-19.6%
Return on equity (TTM)-2.8%14.5%
Debt to equity0-1.36

Performance

NVAX leads 4 of 6 windows
MetricNAMSNVAX
1 week (5 sessions)6.6%-20.9%
1 month (20 sessions)1.6%-24.3%
3 months (63 sessions)-25.1%5.6%
6 months (126 sessions)-43.2%-5.9%
Year to date-42.6%26.9%
1 year (252 sessions)-47.4%18.4%

Technicals

NVAX has the stronger structure
MetricNAMSNVAX
RSI (14)47.337.6
ADX (14)16.724
Price vs 50-day-6.4%-19.1%
Price vs 200-day-30.9%-8.7%
Volatility (1M, annualized)69.8%97.1%

Risk

NAMS is the more resilient
MetricNAMSNVAX
Beta1.432.12
Sharpe ratio-0.910.56
Sortino ratio-1.250.93
Max drawdown-54.4%-34.6%
Current drawdown-51.4%-33.5%
Annualized volatility53.8%73.6%
Value at risk (95%)-5.2%-6.1%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which has more analyst upside, NAMS or NVAX?

Analyst price targets imply +202.9% upside for NAMS and -6.2% for NVAX, so the Street currently favors NAMS. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, NAMS or NVAX?

Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, NAMS or NVAX?

NAMS on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, NAMS or NVAX?

NVAX on the Momentum factor, by 55 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, NAMS or NVAX?

NAMS is the more resilient of the two, so the other name carries the higher downside risk. NAMS on Risk Resilience, by 10 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is NAMS more profitable than NVAX?

The profitability evidence is mixed: gross margin 97.8% vs 77.3%; operating margin -9% vs -19.6%; ttm roe -2.8% vs 14.5%. NAMS leads on two measures and NVAX on one measure, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.

What do the current signals say about NAMS and NVAX?

NAMS: 1 bullish / 3 bearish / 2 neutral, conflicted. NVAX: 2 bullish / 2 bearish / 2 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on NAMS is Death Cross Active (bearish, long horizon). On NVAX it is Golden Cross Active (bullish, long horizon).

Compare NAMS and NVAX with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.